Published Date: 3-Feb-2021
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Eye Health Supplements Market, published by KBV research, The Global Eye Health Supplements Market size is expected to reach $2.4 billion by 2026, rising at a market growth of 10% CAGR during the forecast period.
The flavonoids segment is expected to show a significant growth over the forecast period. It is accredited to the increasing demand for bilberry supplements by the consumers. Bilberry extract is one of the major eye health supplements, is widely used to relieve eye fatigue and it is also used for the treatment of many eye disorders such as glaucoma, cataracts, and near-sightedness. The easy and affordable availability of bilberry extract for eye health is one of the major factors driving the use of flavonoids as eye health supplements, this in turn positively impacting the market growth.
The tablets segment maintained the dominance in the eye health supplements market and had the largest revenue share in 2019. A rising preference for tablet formulation as eye health supplements due to their high accessibility in numerous forms like sustained-release tablets, chewable tablets, and sublingual and buccal tablets, and it is contributing to the growth of this segment growth. In addition to it, since tablets are cheaper than other supplement forms and their extensive adoption among patients of all age groups are driving the market growth.
North America procured the highest market revenue in 2019. This is accredited to the growing occurrence of chronic eye disorders, along with increasing awareness and easy availability of commercialized eye health supplements. In addition to it, in the past few years, product launches for eye health supplements have been significantly increased in this region, this, in turn, is propelling the market growth. The Europe market would showcase a CAGR of 9.6% during (2020 - 2026). Additionally, The Asia Pacific market is estimated to grow at a CAGR of 11.4% during (2020 - 2026).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of The Nature’s Bounty Co. (The Carlyle Group L.P.), Pfizer, Inc., Alticor Inc. (Amway Corporation), Novartis AG, Kemin Industries, Inc., ZeaVision LLC (EyePromise), EyeScience Labs, LLC, Vitabiotics Ltd., Nutrivein and NutraChamps, Inc.
By Ingredient Type
Unique Offerings from KBV Research